CTNM SCHEDULE 13G: SEC filing
Squadron Capital
Filed with the SEC on · accession 0002050709-26-000029
CTNM filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 28, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.8% by the first close after the filing.
Summary of the filing
Squadron Capital filed a Schedule 13G disclosing a passive ownership position in Contineum Therapeutics, Inc. The filing indicates a stake of less than 5% or a passive investment position.
Key details
How CTNM stock reacted
Close before
$8.99
Oct 27, 2026
First close after
+1.78%
$9.15
5 trading days
+7.79%
$9.69
Since filing
+5.90%
$9.52
✦ Ask GOAX AI about this filing — what it means for CTNM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CTNM?
Click hereFrequently asked questions
What did CTNM file with the SEC on Oct 28, 2026?
CTNM filed a SCHEDULE 13G (SEC filing). Squadron Capital filed a Schedule 13G disclosing a passive ownership position in Contineum Therapeutics, Inc. The filing indicates a stake of less than 5% or a passive investment position.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did CTNM stock react to this filing?
CTNM closed at $8.99 before the filing and $9.15 on Oct 28, 2026 (+1.78%). Five trading days later: $9.69 (+7.79%).
Other CTNM SEC filings
- SCHEDULE 13G/A · SEC filingNov 6, 2026
- SCHEDULE 13G · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- SCHEDULE 13G/A · SEC filingOct 28, 2026
- SCHEDULE 13G · SEC filingOct 22, 2026
- 8-K · Fda rejectionSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingJul 30, 2026
- 8-K · SEC filingJul 30, 2026
Get alerts when CTNM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days